Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation
暂无分享,去创建一个
[1] J. Lieberman,et al. The Effects of Clozapine on Tardive Dyskinesia , 1991, British Journal of Psychiatry.
[2] J. Lieberman,et al. The prevalence of tardive dyskinesia. , 1991, Journal of clinical psychopharmacology.
[3] Freer Cb. Care of the elderly. Old myths. , 1985 .
[4] J. Ross,et al. DILTIAZEM FOR TARDIVE DYSKINESIA , 1987, The Lancet.
[5] G. Bagdy,et al. Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment , 1985, Acta psychiatrica Scandinavica.
[6] P. Liddle,et al. Negative Symptoms as a Risk Factor for Tardive Dyskinesia in Schizophrenia , 1993, British Journal of Psychiatry.
[7] R. Conley,et al. Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design , 1993, Schizophrenia Research.
[8] J. Lieberman,et al. Tardive dyskinesia: prevalence, incidence, and risk factors. , 1988, Psychopharmacology. Supplementum.
[9] J. Lieberman,et al. Integrating incidence and prevalence of tardive dyskinesia. , 1986, Psychopharmacology bulletin.
[10] A J Cross,et al. Abnormal Involuntary Movements in Schizophrenia: Are They Related to the Disease Process or Its Treatment? Are They Associated with Changes in Dopamine Receptors? , 1982, Journal of clinical psychopharmacology.
[11] T. Crow,et al. Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.
[12] D. Jeste,et al. ALPHA-TOCOPHEROL IN TARDIVE DYSKINESIA , 1987, The Lancet.
[13] D. Charney,et al. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia , 1989, Biological Psychiatry.
[14] Alogia, attentional impairment, and inappropriate affect: Their status in the dimensions of schizophrenia , 1993 .
[15] D. Tarsy,et al. Withdrawal syndromes associated with antipsychotic drugs. , 1978, The American journal of psychiatry.
[16] C. Wise,et al. PLATELET MONOAMINE OXIDASE AND PLASMA DOPAMINE β-HYDROXYLASE IN TARDIVE DYSKINESIA , 1979, The Lancet.
[17] D. V. Jeste,et al. Tardive dyskinesia. , 1993, Schizophrenia bulletin.
[18] Nagley Mm,et al. Para-amino-salicylic acid in pulmonary tuberculosis. , 1949, Lancet.
[19] J. Gerlach,et al. γ-Acetylenic GABA in Tardive Dyskinesia , 1980 .
[20] P. Liddle,et al. Negative Symptoms, Tardive Dyskinesia and Depression in Chronic Schizophrenia , 1989, British Journal of Psychiatry.
[21] N C Andreasen,et al. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.
[22] J. Kane,et al. Research diagnoses for tardive dyskinesia. , 1982, Archives of general psychiatry.
[23] Schen Rj. Letter: Chlorpropamide hypoglycaemia. , 1973 .
[24] N. Andreasen,et al. Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia , 1994, Neuropsychopharmacology.